Desloratadine 5 mg
Sponsors
Organon and Co, Universitaire Ziekenhuizen KU Leuven
Conditions
Dermal PruritusDermatitisEczemaPerennial Allergic RhinitisPruritusSeasonal Allergic Rhinitis
Phase 3
Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)
CompletedNCT01916980
Start: 2013-08-27End: 2014-03-22Updated: 2024-06-18
A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)
CompletedNCT01918033
Start: 2013-08-20End: 2014-01-26Updated: 2024-06-18
Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
CompletedNCT02320396
Start: 2015-01-09End: 2015-04-27Updated: 2024-05-17
Phase 4
Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177)
CompletedNCT00783133
Start: 2002-11-01End: 2003-06-01Updated: 2024-08-15
Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)
CompletedNCT00794768
Start: 2002-11-30End: 2003-07-31Updated: 2022-02-17
Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)
CompletedNCT00794248
Start: 2002-11-30End: 2003-05-31Updated: 2022-02-17